EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancements in mesenchymal stem cell therapy for chronic wounds: challenges, innovations, and future directions

Yi Tang, Tong Su, Baochuan Huang, Qihong Xu, Qingjiang Chen, Saiqiong Zhang, Wuquan Li

Frontiers in Cell and Developmental Biology · 12.01.2026 · 13

DOI: 10.3389/fcell.2025.1730032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.01.2026. Verfasst von Yi Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burn Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of chronic wounds remains challenging due to their complex pathophysiology, poor response to conventional therapies, and significant impact on patients’ quality of life. mesenchymal stem cells (MSCs) have garnered attention as a potential treatment due to their regenerative and immunomodulatory properties. This review summarizes preclinical and clinical advancements in MSC-based therapies for chronic wound healing. MSCs promote tissue regeneration through various mechanisms, including differentiation into skin cell lineages, modulation of inflammation, angiogenesis, and paracrine release of bioactive factors. Current research focuses on identifying viable MSC sources, optimizing delivery methods, and understanding their mechanisms for clinical use. Despite progress, challenges remain, including inconsistent results, poor MSC survival in the wound microenvironment, and variability in regenerative capacity across MSC sources. Future research should focus on developing standardized guidelines for MSC preparation and conducting long-term randomized trials to assess safety, efficacy, and potential risks. In conclusion, this review highlights current evidence and identifies key challenges for the clinical application of MSCs in chronic wound healing.

Schlagwörter

Stichwörter der Autor:innen

angiogenesischronic woundsimmune modulationmesenchymal stem cellsparacrine signalingregenerative medicine

Autor:innen und Institutionen

  • Department of Burn Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Zitieren

APA

Tang, Y., Su, T., Huang, B., Xu, Q., Chen, Q., Zhang, S., & Li, W. (2026). Advancements in mesenchymal stem cell therapy for chronic wounds: challenges, innovations, and future directions. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1730032

Vancouver

Tang Y, Su T, Huang B, Xu Q, Chen Q, Zhang S, et al. Advancements in mesenchymal stem cell therapy for chronic wounds: challenges, innovations, and future directions. Frontiers in Cell and Developmental Biology. 2026;13. doi:10.3389/fcell.2025.1730032

BibTeX
@article{Tang2026,
  author = {Tang, Yi and Su, Tong and Huang, Baochuan and Xu, Qihong and Chen, Qingjiang and Zhang, Saiqiong and Li, Wuquan},
  title = {Advancements in mesenchymal stem cell therapy for chronic wounds: challenges, innovations, and future directions},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcell.2025.1730032}
}
Kostenlos starten →